This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Does salvage radiation therapy change the biology of recurrent prostate cancer based on PSA doubling times? Results from the SEARCH database - Abstract
May 21, 2012
AUA 2012 - Trends in the use of incontinence procedures after radical prostatectomy: A population-based analysis - Session Highlights
May 21, 2012
AUA 2012 - A comparison of biochemical recurrence rates of open and robotic prostatectomy at a large tertiary care center - Session Highlights
May 21, 2012
AUA 2012 - One year updated comparative cost analysis of open and robotic-assisted radical prostatectomy - Session Highlights
May 20, 2012
AUA 2012 - Urinary continence (UC) and sexual function (SF) among men with localized prostate cancer treated with active surveillance (AS), radical prostatectomy (RP), and brachytherapy (PI) - Session Highlights
May 20, 2012
Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance - Abstract
May 18, 2012
Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro - Abstract
May 18, 2012
Diffusion-weighted imaging with relative signal intensity statistical thresholding for delineating prostate cancer tumors - Abstract
May 18, 2012
Active surveillance for prostate cancer: Past, present and future - Abstract
May 18, 2012
Intra-fractional set-up and organ motion errors in intensity-modulated radiation therapy for prostate cancer - Abstract
May 18, 2012
Prostate-specific antigen testing in older men in the USA: Data from the behavioral risk factor surveillance system - Abstract
May 18, 2012
Choline PET and PET/CT in primary diagnosis and staging of prostate cancer - Abstract
May 18, 2012
DWI-MRI: Single, informative, and noninvasive technique for prostate cancer diagnosis - Abstract
May 18, 2012
Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective - Abstract
May 18, 2012
Role of 5α-reductase inhibitors in prostate cancer prevention and treatment - Abstract
May 18, 2012
External validation of the cancer of the prostate risk assessment score to predict biochemical relapse after radical prostatectomy for prostate cancer in Japanese patients - Abstract
May 18, 2012
Does extended prostate needle biopsy improve the concordance of Gleason scores between biopsy and prostatectomy in the Taiwanese population? - Abstract
May 18, 2012
The long-term results with delayed-combined androgen blockade therapy in local or locally advanced prostate cancer - Abstract
May 18, 2012
Locally advanced prostate cancer: Three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy - Abstract
May 18, 2012
Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy - Abstract
May 18, 2012
Page 1292 of 1435
Start
Prev
1287
1288
1289
1290
1291
1292
1293
1294
1295
1296
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free